{ "items": [ "\n\n
\n \n Journal article\n \n
\n \n\n \n \n \nBowles EJ. et al, (2014), PLoS ONE, 9, e114709 - e114709
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nOndondo B. et al, (2014), IMMUNOLOGY, 143, 146 - 146
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nClutton G. et al, (2014), AIDS, 28, 2495 - 2504
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nOndondo B. et al, (2014), Clin Vaccine Immunol, 21, 1565 - 1572
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nNjuguna IN. et al, (2014), Vaccine, 32, 5801 - 5808
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nNjuguna IN. et al, (2014), Vaccine, 32, 5801 - 5808
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nMor\u00f3n-L\u00f3pez S. et al, (2014), AIDS Research and Human Retroviruses, 30, A190 - A190
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nBorthwick NJ. et al, (2014), AIDS Research and Human Retroviruses, 30, A187 - A187
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nHayton E-J. et al, (2014), PLoS ONE, 9, e101591 - e101591
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nNaarding MA. et al, (2014), J Immunol Methods, 409, 161 - 173
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nHanke T., (2014), Expert Opin Biol Ther, 14, 601 - 616
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nChen L. et al, (2014), Arthritis & Rheumatology, 66, 284 - 294
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nBorthwick N. et al, (2014), Molecular Therapy, 22, 464 - 475
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nNaarding MA. et al, (2014), Journal of Immunological Methods, 409, 161 - 173
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nSaubi N. et al, (2014), Mol Ther Methods Clin Dev, 1
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nNjuguna I. et al, (2014), Retrovirology : research and treatment, 6, 1 - 5
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nClutton G. et al, (2014), AIDS, 28, 2495 - 2504
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nBorthwick N. et al, (2014), Molecular Therapy, 22, 464 - 475
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nKoopman G. et al, (2013), AIDS, 27, 2841 - 2851
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nOndondo B. et al, (2013), Vaccine, 31, 5594 - 5601
\n \n \n \n\n \n
\n \n \n